Vinay K Pattalachinti

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Binding Protein

Top Venues

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Vinay K Pattalachinti, Ichiaki Ito, Saikat Chowdhury, Abdelrahman M G Yousef, Yue Gu, Betul Beyza Gunes, Emma R Salle, Melissa W Taggart, Keith F Fournier, Natalie Wall Fowlkes, John Paul Shen
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Molecular cancer research : MCR 22 (4) (2024)
Vinay K Pattalachinti, Ichiaki Ito, Saikat Chowdhury, Abdelrahman M G Yousef, Yue Gu, Betul Beyza Gunes, Emma R Salle, Melissa W Taggart, Keith F Fournier, Natalie Wall Fowlkes, John Paul Shen
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Molecular cancer research : MCR 22 (4) (2024)
Vinay K Pattalachinti, Ichiaki Ito, Saikat Chowdhury, Abdelrahman M G Yousef, Yue Gu, Betul Beyza Gunes, Emma R Salle, Melissa W Taggart, Keith F Fournier, Natalie Wall Fowlkes, John Paul Shen
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Molecular cancer research : MCR (2024)
Vinay K Pattalachinti, Ichiaki Ito, Saikat Chowdhury, Abdelrahman M G Yousef, Yue Gu, Betul Beyza Gunes, Emma R Salle, Melissa W Taggart, Keith F Fournier, Natalie Wall Fowlkes, John Paul Shen
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Molecular cancer research : MCR 22 (4) (2024)
Vinay K Pattalachinti, Ichiaki Ito, Saikat Chowdhury, Abdelrahman M G Yousef, Yue Gu, Betul Beyza Gunes, Emma R Salle, Melissa W Taggart, Keith F Fournier, Natalie Wall Fowlkes, John Paul Shen
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Molecular cancer research : MCR 22 (4) (2024)